The NSW government launched its BioFirst program in September last year. Like most other governments' biotech programs, the NSW initiative involves several government departments. [ + ]

Biotech in NSW doesn't appear to depend on fancy government packages, but new infrastructures are changing the face of bio in the First State. [ + ]

In the last month, three of Australia's most experienced listed biotechs have endured roller coaster rides on the stock market, in the case of all three because of upheaval at the board level. [ + ]

Just over a month ago, with his company on the verge of big new international deals, Peptech managing director Stephen Kwik agreed to leave the company so the board could replace him with a CEO with scientific background and commercial expertise. [ + ]

Scientist-turned-financier Dr Kevin Healey is one of an elite group which has used its life science credentials as a springboard to make a splash as venture capitalists. [ + ]

Queensland is cooking up a thriving biotech sector by successfully blending half a dozen hard-to-find ingredients. [ + ]

Kate Parker helped nurture Invest Australia through its initial growth spurt 18 months ago. Now with the Commonwealth government agency growing again, restructuring and on the brink of becoming independent, Parker is leaving. [ + ]

Cash-strapped biotech startups are increasingly rewarding their staff with shares in the company. [ + ]

One of the spin-offs of Australia's burgeoning biotech sector is an increasingly competitive recruitment sector. [ + ]

Distributed processing gets an updated look as vendors go for the grid: In early 2000, Cereon Genomics had a serious situation on its hands: It was running out of computing power. [ + ]

Stan Yakatan, "US venture capital raising guru" and strategic biotechnology adviser to the Victorian government, sits at a table in The Westin Melbourne's Allegro restaurant surrounded by breakfast, documents and five chairs intermittently filled and vacated biotech movers and shakers. [ + ]

Venture capitalists complain they are finding it ever-tougher to coax fresh funds from investors. Yet paradoxically, the total Australian pool of life science risk capital stands at record levels. [ + ]

Spend any time in the biobusiness sector and you learn one thing very quickly: it pays to be bilingual. And not in French or Spanish or Japanese, but in the languages of science and money. [ + ]

Barely a week goes by when an overseas business expert isn't out here telling Australian companies how it should be done. [ + ]

Plant genetics is a driving force in agricultural biotech in Australia, affecting the commercial crop industries, horticulture, forestry and viticulture. Even livestock industries have plant biotechnology programs to develop improved pasture crops. [ + ]